DiaSorin SpA is a leading pharmaceutical company based in Italy that specializes in developing reagent kits for laboratory diagnostics worldwide. With a low ESG risk rating score of 19.5, DiaSorin focuses on immunodiagnostic and molecular diagnostics in the Life Science sector. The company operates globally, with a strong presence in Italy, Europe, North America, and other regions. Its primary revenue comes from North America and Italy.